128 related articles for article (PubMed ID: 21138059)
1. A new class of antimetabolites: pyridine thioglycosides as potential anticancer agents.
Elgemeie GH; Mahdy EM; Elgawish MA; Ahmed MM; Shousha WG; Eldin ME
Z Naturforsch C J Biosci; 2010; 65(9-10):577-87. PubMed ID: 21138059
[TBL] [Abstract][Full Text] [Related]
2. Antimetabolites: Design, synthesis, and cytotoxic evaluation of novel dihydropyridine thioglycosides and pyridine thioglycosides.
Elgemeie GH; Fathy NM; Farag AB; Alkursani SA
Nucleosides Nucleotides Nucleic Acids; 2017 May; 36(5):355-377. PubMed ID: 28387606
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo anti-proliferative evaluation of bis(4'-(4-tolyl)-2,2':6',2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors.
Mahendiran D; Kumar RS; Viswanathan V; Velmurugan D; Rahiman AK
J Biol Inorg Chem; 2017 Oct; 22(7):1109-1122. PubMed ID: 28884428
[TBL] [Abstract][Full Text] [Related]
4. Solanum tuberosum lectin inhibits Ehrlich ascites carcinoma cells growth by inducing apoptosis and G2/M cell cycle arrest.
Kabir SR; Rahman MM; Amin R; Karim MR; Mahmud ZH; Hossain MT
Tumour Biol; 2016 Jun; 37(6):8437-44. PubMed ID: 26733170
[TBL] [Abstract][Full Text] [Related]
5. A study on the role of (+)-catechin in suppression of HepG2 proliferation via caspase dependent pathway and enhancement of its in vitro and in vivo cytotoxic potential through liposomal formulation.
Jain P; Kumar N; Josyula VR; Jagani HV; Udupa N; Mallikarjuna Rao C; Vasanth Raj P
Eur J Pharm Sci; 2013 Nov; 50(3-4):353-65. PubMed ID: 23954456
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo anticancer activity evaluation of ursolic acid derivatives.
Shao JW; Dai YC; Xue JP; Wang JC; Lin FP; Guo YH
Eur J Med Chem; 2011 Jul; 46(7):2652-61. PubMed ID: 21514015
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic activity of N-(2-hydroxybenzylidene)2'-hydroxyphenylimine aqua nickel(II) complex [NI(H₂O)HHP] on ehrlich ascites carcinoma (EAC) in Swiss albino mice.
Hossain IA; Khanam JA; Jesmin M; Ali MM
Exp Toxicol Pathol; 2016 Jan; 68(1):15-25. PubMed ID: 26404919
[TBL] [Abstract][Full Text] [Related]
8. Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2-carboxylate derivatives: in vitro evaluation, cell cycle analysis and QSAR studies.
Abreu RM; Ferreira IC; Calhelha RC; Lima RT; Vasconcelos MH; Adega F; Chaves R; Queiroz MJ
Eur J Med Chem; 2011 Dec; 46(12):5800-6. PubMed ID: 22014996
[TBL] [Abstract][Full Text] [Related]
9. Novel Nucleoside Analogues: First Synthesis of Pyridine-4-Thioglycosides and Their Cytotoxic Evaluation.
Elgemeie G; Abou-Zeid M; Alsaid S; Hebishy A; Essa H
Nucleosides Nucleotides Nucleic Acids; 2015; 34(10):659-73. PubMed ID: 26462063
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in Vitro Anti-Tumor Activity of A New Class of Acyclic Thioglycosides.
Elgemeie GH; Saber NM
Nucleosides Nucleotides Nucleic Acids; 2015; 34(7):463-74. PubMed ID: 26158566
[TBL] [Abstract][Full Text] [Related]
11. C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice.
Bevara GB; Kumar ADN; Koteswramma K L; Badana AK; Kumari S; Yarla NS; Malla RR
Anticancer Agents Med Chem; 2017; 17(9):1256-1266. PubMed ID: 28044935
[TBL] [Abstract][Full Text] [Related]
12. Influence of gold nanoparticle tagged snake venom protein toxin NKCT1 on Ehrlich ascites carcinoma (EAC) and EAC induced solid tumor bearing male albino mice.
Bhowmik T; Saha PP; DasGupta AK; Gomes A
Curr Drug Deliv; 2014; 11(5):652-64. PubMed ID: 24827982
[TBL] [Abstract][Full Text] [Related]
13. New di(hetero)arylethers and di(hetero)arylamines in the thieno[3,2-b]pyridine series: synthesis, growth inhibitory activity on human tumor cell lines and non-tumor cells, effects on cell cycle and on programmed cell death.
Queiroz MJ; Peixoto D; Calhelha RC; Soares P; Dos Santos T; Lima RT; Campos JF; Abreu RM; Ferreira IC; Vasconcelos MH
Eur J Med Chem; 2013 Nov; 69():855-62. PubMed ID: 24121236
[TBL] [Abstract][Full Text] [Related]
14. A new acridine derivative induces cell cycle arrest and antiangiogenic effect on Ehrlich ascites carcinoma model.
Mangueira VM; Batista TM; Brito MT; Sousa TKG; Cruz RMDD; Abrantes RA; Veras RC; Medeiros IA; Medeiros KKP; Pereira ALDC; Serafim VL; Moura RO; Sobral MV
Biomed Pharmacother; 2017 Jun; 90():253-261. PubMed ID: 28364597
[TBL] [Abstract][Full Text] [Related]
15. Novel Pyrazolo[3,4-b]pyridine Derivatives: Synthesis, Characterization, Antimicrobial and Antiproliferative Profile.
Salem MS; Ali MA
Biol Pharm Bull; 2016; 39(4):473-83. PubMed ID: 27040621
[TBL] [Abstract][Full Text] [Related]
16. Anticancer activity and toxicity profiles of 2-benzylidene indanone lead molecule.
Singh A; Fatima K; Singh A; Behl A; Mintoo MJ; Hasanain M; Ashraf R; Luqman S; Shanker K; Mondhe DM; Sarkar J; Chanda D; Negi AS
Eur J Pharm Sci; 2015 Aug; 76():57-67. PubMed ID: 25933717
[TBL] [Abstract][Full Text] [Related]
17. A p-menth-1-ene-4,7-diol (EC-1) from Eucalyptus camaldulensis Dhnh. triggers apoptosis and cell cycle changes in Ehrlich ascites carcinoma cells.
Islam F; Khanam JA; Khatun M; Zuberi N; Khatun L; Kabir SR; Reza MA; Ali MM; Rabbi MA; Gopalan V; Lam AK
Phytother Res; 2015 Apr; 29(4):573-81. PubMed ID: 25583285
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
[TBL] [Abstract][Full Text] [Related]
19. The triterpenoid fraction from Trichosanthes dioica root exhibits antiproliferative activity against Ehrlich ascites carcinoma in albino mice: involvement of possible antioxidant role.
Bhattacharya S; Haldar PK
J Exp Ther Oncol; 2012; 9(4):281-90. PubMed ID: 22545421
[TBL] [Abstract][Full Text] [Related]
20. Antitumor efficacy and amelioration of oxidative stress by Trichosanthes dioica root against Ehrlich ascites carcinoma in mice.
Bhattacharya S; Prasanna A; Majumdar P; Kumar RB; Haldar PK
Pharm Biol; 2011 Sep; 49(9):927-35. PubMed ID: 21819262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
